NDC 68828-170-01 - Light Skin Defense Concealer Broad Spectrum SPF 15 Jafra
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68828-170
- Requested NDC
- 68828-170-01
- Package NDCs from labels
- 68828-170-01, 68828-170-02
- Manufacturer
- Jafra Cosmetics International Inc | Distribuidora Comercial Jafra, S.A. de C.V.
- Effective date
- 2024-01-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Skin Defense Concealer SPF 15 | Jafra Cosmetics International Inc | Distribuidora Comercial Jafra, S.A. de C.V. | 2024-01-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68828-170-01 | Light Skin Defense Concealer Broad Spectrum SPF 15Jafra | 15 mL in 1 TUBE | CREAM | 15 | 11 | |
| 68828-170-02 | Light Skin Defense Concealer Broad Spectrum SPF 15Jafra | 1 in 1 CARTON | CREAM | 1 | 11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68828-170 | LIGHT SKIN DEFENSE CONCEALER BROAD SPECTRUM SPF 15 JAFRA (OCTINOXATE, OCTISALATE, OXYBENZONE) CREAM MEDIUM SKIN DEFENSE CONCEALER BROAD SPECTRUM SPF 15 JAFRA (OCTINOXATE, OCTISALATE, OXYBENZONE) CREAM DARK SKIN DEFENSE CONCEALER BROAD SPECTRUM SPF 15 JAFRA (OCTINOXATE, OCTISALATE, OXYBENZONE) CREAM [JAFRA COSMETICS INTERNATIONAL INC] | 11 | Legacy NDC, 2 package rows | 20240109_3d261d0d-a122-4e5e-86ac-89a19d3e8999.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.